$ADRO News Article - Aduro Biotech Announces Prese
Post# of 11
(Total Views: 170)
Posted On: 11/08/2019 4:15:42 PM
$ADRO News Article - Aduro Biotech Announces Presentation of Results from First-in-Human Phase 1 Study of Anti-CD27 Agonist as Monotherapy and in Combination with Pembrolizumab in Patients with Advanced Solid Tumors at the Society for Immunotherapy of Cancer 34th Annual Meeti https://marketwirenews.com/news-releases/adur...27557.html
(0)
(0)Chinook Therapeutics, Inc. (KDNY) Stock Research Links
My Twitter: WhyteStocks
Scroll down for more posts ▼